Macrolide resistance

Drug Resistance Updates

Volumn 1, Issue 1, 1998, Pages 29-41

  Weisblum, Bernard ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002136086     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80212-4     Document Type: Review

References (97)

1. In: Bryskier A.J., Butzler J.P., Neu H.C., and Tulkens P.M. (Eds). Macrolides: Chemistry, Pharmacology and Clinical Uses (1993), Arnette Blackwell, Paris
2. Arthur M., Andremont A., and Courvalin P. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrobial Agents Chemother 31 (1987) 404-409
3. Ounissi H., and Courvalin P. Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli. Gene 35 (1985) 271-278
4. Wondrack L., Massa M., Yang B.V., and Sutcliffe J. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrobial Agents Chemother 40 (1996) 992-998
5. Cundliffe E. Glycosylation of macrolide antibiotics in extracts of Streptomyces lividans. Antimicrobial Agents Chemother 36 (1992) 348-352
6. Vilches C., Hernandez C., Mendez C., and Salas J.A. Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus. J Bacteriol 174 (1992) 161-165
7. Ohara K., Kanda T., Ohmiya T.K., Ebisu T., and Kono M. Purification and characterization of macrolide 2′-phosphotransferase from a strain of E. coli that is highly resistant to erythromycin. Antimicrobial Agents Chemother 33 (1989) 1354-1357
8. Kono M., O'Hara K., and Ebisu T. Purification and characterization of macrolide 2′-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics. FEMS Microbiol Lett 76 (1992) 89-94
9. Noguchi N., Katayama J., and O'Hara K. Cloning and nucleotide sequence of the mphB gene for macrolide 2′-phosphotransferase II in Escherichia coli. FEMS Microbiol Lett 144 (1996) 197-202
10. Kim S.K., Baek M.C., Choi S.S., Kim B.K., and Choi E.C. Nucleotide sequence expression and transcriptional analysis of the Escherichia coli mphK gene encoding macrolide phosphotransferase. Molecules Cells 6 (1996) 153-160
11. Birmingham V.A., Cox K.L., Larson J.L., Fishman S.E., Hershberger C., and Seno E.T. Cloning and expression of a tylosin resistance gene from a tylosin-producing strain of Streptomyces fradiae. Mol Gen Genet 204 (1986) 532-539
12. Richardson M.A., Kuhstoss S., Solenberg P., Schaus N.A., and Rao R.N. A new shuttle cosmid vector, pKC505, for streptomycetes: its use in the cloning, of three different spiramycin-resistance genes from a Streptomyces ambofaciens library. Gene 61 (1987) 231-241
13. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrobial Agents Chemother 39 (1995) 577-585
14. Weisblum B. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrobial Agents Chemother 39 (1995) 797-805
15. Noller H.F., Kop J., Wheaton V., et al. Secondary structure model for 23S ribosomal RNA. Nucleic Acids Res 9 (1981) 6167-6189
16. Douthwaite S., Prince J.B., and Noller H.F. Evidence for functional interaction between domains II and V of 23S ribosomal RNA from an erythromycin resistant mutant. Proc Natl Acad Sci USA 82 (1985) 8330-8334
17. Barta A., Steiner G., Brosius J., Noller H.F., and Kuechler E. Identification of a site on 23S ribosomal RNA located at the peptidyl transferase center. Proc Natl Acad Sci USA 81 (1984) 3607-3611
18. Lai C.J., and Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci USA 68 (1971) 856-860
19. Skinner R., Cundliffe E., and Schmidt F.J. Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. J Biol Chem 258 (1983) 12702-12706
20. Gryczan T., Grandi G., Hahn J., Grandi R., and Dubnau D. Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance. Nucleic Acids Res 8 (1980) 6081-6097
21. Horinouchi S., and Weisblum B. Post-transcriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc Natl Acad Sci USA 77 (1980) 7079-7083
22. Kwak J.H., Choi E.C., and Weisblum B. Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis. J Bacteriol 173 (1991) 4725-4735
23. Allen N.E. Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance. Antimicrobial Agents Chemother 11 (1977) 669-674
24. Kamimiya S., and Weisblum B. Induction of ermSV by 16-membered ring macrolides. Antimicrobial Agents Chemother 41 (1997) 530-534
25. Jenkins G., and Cundliffe E. Cloning and characterization of two genes from Streptomyces lividans that confer inducible resistance to lincomycin and macrolide antibiotics. Gene 108 (1991) 55-62
26. Memili E., and Weisblum B. Essential role of endogenously synthesized tylosin for induction of ermSF in Streptomyces fradiae. Antimicrobial Agents Chemother 41 (1997) 1203-1205
27. Meier A., Kirschner P., Springer B., Steingrub V.A., Brown B.A., Wallace R.J., and Böttger E.C. Identification of mutations in the 23S ribosomal RNA gene of clarithromycin resistant Mycobacterium intracellulare. Antimicrobial Agents Chemother 38 (1994) 381-384
28. Desmyter J. Lincomycin resistance of erythromycin-resistant cocci. N Engl J Med 278 (1968) 967
29. Watanakunakorn C. Clindamycin therapy of Staphylococuus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin, and erythromycin. Am J Med 60 (1976) 419-425
30. Leclercq R., and Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrobial Agents Chemother 35 (1991) 1267-1272
31. Mazzei T., Mini E., Novelli A., and Periti P. Chemistry and mode of action of macrolides. J Antimicrob Chemother 31 Suppl C (1993) 1-9
32. Ross J.I., Eady E.A., Cove J.H., et al. Clinical resistance to erythromycin and clindamycin in cutaneous Propionibacteria isolated from patients is associated with mutations in 23S rRNA Antimicrobial Agents Chemother 41 (1997) 1162-1165
33. Versalovic J., Shortridge D., Kibler K., et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents Chemother 40 (1996) 477-480
34. Pernodet J.L., Boccard F., Alegre M.T., Blondelet-Rouault M.H., and Guérineau M. Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens. EMBO J 7 (1988) 277-282
35. Pernodet J.L., Boccard F., Alegre M.T., Gagnat J., and Guérineau M. Organization and nucleotide sequence analysis of a ribosomal RNA gene cluster from Streptomyces ambofaciens. Gene 79 (1989) 33-46
36. Dam M., Douthwaite S., Tenson T., and Mankin A.S. Mutations in domain II of 23S rRNA facilitate translation of a 23S rRNA-encoded pentapeptide conferring erythromycin resistance. J Mol Biol 259 (1996) 1-6
37. Tenson T., Deblasio A., and Mankin A. A functional peptide encoded in the Escherichia coli 23S rRNA. Proc Natl Acad Sci USA 93 (1996) 5641-5646
38. Tenson T., Xiong L.Q., Kloss P., and Mankin A.S. Erythromycin resistance peptides selected from random peptide libraries. J Biol Chem 272 (1997) 17425-17430
39. Lewis K. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem Sci 19 (1994) 119-123
40. Dinh T., Paulsen I.T., and Saier Jr. M.H. A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria. J Bacteriol 176 (1994) 3825-3831
41. Paulsen I.T., Brown M.H., and Skurray R.A. Proton-dependent multidrug efflux systems. Microbiol Rev 60 (1996) 575-608
42. Sutcliffe J.A., Tait-Kamradt A., and Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents Chemother 40 (1996) 1817-1824
43. Clancy J., Petitpas J., Dibhajj F., et al. Molecular cloning and functional analysis of a novel macrolide resistance determinant, MEFA, from Streptococcus pyogenes. Mol Microbiol 22 (1996) 867-879
44. Tait-Kamradt A., Clancy J., Cronan M., Dib-Haji F., Wondrack L., Yuan W., and Sutcliffe J. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrobial Agents Chemother 41 (1997) 2251-2255
45. Ross J.I., Farrell A.M., Eady E.A., Cove J.H., and Cunliffe W.J. Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrobial Chemother 24 (1989) 851-862
46. Ross J.I., Eady E.A., Cove J.H., Cunliffe W.J., Baumberg S., and Wootton J.C. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol 4 (1990) 1207-1214
47. Ross J.I., Eady E.A., Cove J.H., and Baumberg S. Minimal functional system required for expression of erythromycin resistance by MSRA in Staphylococcus aureus RN4220. Gene 183 (1996) 143-148
48. Jánosi L., Nakajima Y., and Hashimoto H. Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus. Microbiol Immunol 34 (1990) 723-735
49. Matsuoka M., Endou K., Saitoh S., Katoh M., and Nakajima Y. A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary. Biol Pharm Bull 18 (1995) 1482-1486
50. Matsuoka M., Endou K., Kobayashi H., Inoue M., and Nakajima Y. A dyadic plasmid that shows MLS and PMS resistance in Staphyloccus aureus. FEMS Microbiol Lett 148 (1997) 91-96
51. Nakajima Y., Jánosi L., Endou K., Matsuoka M., and Hashimoto H. Inducible resistance to a 16-membered macrolide, mycinamicin, in Staphylococcus aureus resistant to 14-membered macrolides and streptogramin B antibiotics. J Pharmacobio-Dynamics 15 (1992) 319-324
52. Rosteck Jr. P.R., Reynolds P.A., and Hershberger C.L. Homology between proteins controlling Streptomycs fradiae tylosin resistance and ATP-binding transport. Gene 102 (1991) 27-32
53. Epp J.K., Burgett S.G., and Schoner B.E. Cloning and nucleotide sequence of a carbomycin-resistance gene from Streptomyces thermotolerans. Gene 53 (1987) 73-83
54. Schoner B., Geistlich M., Rosteck Jr. P., et al. Sequence similarity between macrolide-resistance determinants and ATP-binding proteins. Gene 115 (1992) 93-96
55. Aparicio G., Buche A., Mendez C., and Salas J.A. Characterization of the ATPase activity of the N-terminal nucleotide binding domain of an ABC transporter involved in oleandomycin secretion by Streptomyces antibioticus. FEMS Microbiology Lett 141 (1996) 157-162
56. Edgar R., and Bibi E. MDFA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol 179 (1997) 2274-2280
57. Jäger W., Kalinowski J., and Pühler A. A Corynebacterium glutamicum resistance protein conferring multidrug resistance in the heterologous host Escherichia coli. J Bacteriol 179 (1997) 2449-2451
58. Sanchez L., Pan W., Vinas M., and Nikaido H. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J Bacteriol 179 (1997) 6855-6857
59. Hagman K.E., Pan W., Spratt B.G., Balthazar J.T., Judd R.C., and Shafer W.M. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141 (1995) 611-622
60. Choi S.S., Kim S.K., Oh T.G., and Choi E.C. Role of mRNA termination in regulation of ermK. J Bacteriol 179 (1997) 2065-2067
61. Yanofsky C. Transcription attenuation. J Biol Chem 263 (1988) 609-612
62. Weisblum B., Siddhikol C., Lai C.J., and Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. J Bacteriol 106 (1971) 835-847
63. Tai P.C., Wallace B.J., and Davis B.D. Selective action of erythromycin on initiating ribosomes. Biochemistry 13 (1974) 4653-4659
64. Menninger J., and Otto D.P. Erythromycin, carbomycin, and spiramycin, inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes. Antimicrobial Agents Chemother 21 (1982) 811-818
65. Shivakumar A.G., Hahn J., Grandi G., Kozlov Y., and Dubnau D. Post-transcriptional regulation of an erythromycin resistance protein specified by plasmid pE194. Proc Natl Acad Sci USA 77 (1980) 3903-3907
66. Sandler P., and Weisblum B. Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5′-to-3′ nucleolytic cleavage of the ermA transcript. J Bacteriol 171 (1989) 6680-6688
67. Mayford M., and Weisblum B. Conformational alterations in the ermC transcript in vivo during induction. EMBO J 8 (1989) 4307-4314
68. Mayford M., and Weisblum B. ermC leader peptide, amino acid sequence critical for induction by translational attenuation. J Mol Biol 206 (1989) 69-79
69. Mayford M., and Weisblum B. The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics. J Bacteriol 172 (1990) 3772-3779
70. Lovett P.S., and Rogers E.J. Ribosome regulation by the nascent peptide. Microbiol Revs 60 (1996) 366-385
71. Tanaka T., and Weisblum B. Mutant of Staphylococcus aureus with lincomycin- and carbomycin-inducible resistance to erythromycin. Antimicrobial Agents Chemother 5 (1974) 538-540
72. Garrod L.P. The erythromycin group of antibiotics. Br Med J 2 (1957) 57-63
73. Saito T., and Mitsuhashi S. Antibacterial activity of megalomicin and its inducer activity for macrolide resistance in Staphylococci. J Antibiot 24 (1971) 850-854
74. Bourse R., and Monier J. Effet de l'erythromycin sur la croissance de Staph. aureus resistant dissocié en bacteriostase par un autre macrolide ou un antibiotique apparenté. Ann de l'Inst Pasteur (Paris) 113 (1967) 67-79
75. Chabbert Y. Antagonisme in vitro entre l'erythromycine et la spiramycine. Ann Inst Pasteur (Paris) 90 (1956) 787-790
76. Dubnau D. Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics. CRC Crit Rev Biochem 16 (1984) 103-132
77. Farmer S., Li Z.S., and Hancock R.E. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J Antimicrob Chemother 29 (1992) 27-33
78. Vaara M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Antimicrob Agents Chemother 37 (1993) 354-356
79. Bonnefoy A., Girard A.M., Agouridas C., and Chantot J.F. Ketolides lack inducibility properties of MLS(B) resistance phenotype. J Antimicrob Chemother 40 (1997) 85-90
80. Jones R.N., and Biedenbach D.J. Antimicrobial activity of RU-66647, a new ketolide. Diag Microbiol Infect Dis 27 (1997) 7-12
81. Clancy J., Schmieder B.J., Petitpas J.W., et al. Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. J Antibiotics 48 (1995) 1273-1279
82. Yu L., Petros A.M., Schnudel A., et al. Solution structure of an rRNA methyltransferase (ErmAM) that confers MLS antibiotic resistance. Nature Struct Biol 4 (1997) 483-489
83. Horinouchi S., Byeon W.H., and Weisblum B. A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis. J Bacteriol 154 (1983) 1252-1262
84. Kovalic D., Giannattasio R.B., and Weisblum B. Methylation of minimalist 23S rRNA sequences in vitro by ErmSF (TlrA) N-methyltransferase. Biochemistry 34 (1995) 15838-15844
85. Vester B., and Douthwaite S. Domain V of 23S rRNA contains all the structural elements necessary for recognition by the ErmE methyltransferase. J Bacteriol 176 (1994) 6999-7004
86. Kovalic D., Giannattasio R.B., Jin H.J., and Weisblum B. 23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase. J Bacteriol 176 (1994) 6992-6998
87. Oliynyk M., Brown M.J., Cortes J., Staunton J., and Leadlay P.F. A hybrid modular polyketide synthase obtained by domain swapping. Chem Biol 3 (1996) 833-839
88. Ruan X., Pereda A., Stassi D.L., et al. Acyltransferase domain substitutions in erythromycin polyketide synthase yield novel erythromycin derivatives. J Bacteriol 179 (1997) 6416
89. Fu H., and Khosla C. Antibiotic activity of polyketide products derived from combinatorial biosynthesis: implications for directed evolution. Molecular Diversity 1 (1996) 121-124
90. Horinouchi S., and Weisblum B. The control region for erythromycin resistance: free energy changes related to induction and mutation to constitutive expression. Mol Gen Genet 182 (1981) 341-348
91. Hodel A.E., Gershon P.D., Shi X.N., and Quiocho F.A. The 1.85 angstrom structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends. Cell 85 (1996) 247-256
92. Labahn J., Granzin J., Schluckebier G., Robinson D.P., Jack W.E., Schildkraut I., and Saenger W. Three-dimensional structure of the adenine-specific DNA methyltransferase M. Taq I in complex with the cofactor S-adenosylmethionine. Proc Natl Acad Sci USA 91 (1994) 10957
93. Monod M., Mohan S., and Dubnau D. Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus. J Bacteriol 169 (1987) 340-350
94. Kamimiya S., and Weisblum B. Translational attenuation control of ermSF, an inducible resistance determinant encoding rRNA N-methyltransferase from Streptomyces fradiae. J Bacteriol 170 (1988) 1800-1811
95. Accession number U59450. Kamimiya S., and Weisblum B. Genebank deposit: Streptomyces viridochromogenes rRNA (adenine-N6-)-methyltransferase, ermSV gene (1996)
96. Hodgson A.L., Krywult J., and Radford A.J. Nucleotide sequence of the erythromycin resistance gene from the Corynebacterium plasmid pNG2. Nucleic Acids Res 18 (1990) 1891
97. Dahl M.K., and Meinhof C.G. A series of integrative plasmids for Bacillus subtilis containing unique cloning sites in all three open reading frames for translational lacZ fusions. Gene 145 (1994) 151-152